• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312
Citation: ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312

Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease

Funds: This study was supported by the National Natural Science Foundation of China (No. 81673435,No.81872850,No.82073755)
More Information
  • Received Date: January 15, 2021
  • Revised Date: May 16, 2021
  • To investigate the effects of VHL (von Hippel-Lindau) inhibitor on Caenorhabditis elegans (C.elegans) model of Parkinson''s disease (PD),C.elegans were exposed to rotenone and treated with VHL inhibitor VH298.The death,dopaminergic neurodegeneration and mitochondrial unfolded protein response (mito-UPR) of transgenic strains with the markers zcIs9 and otIs181 exposed to different concentrations of rotenone were investigated. The death,dopaminergic neurodegeneration,and changes of behaviors including head thrashes,body bends and foraging behavior of C.elegans model of PD treated with different concentrations of VH298 were explored.The results showed that different concentrations of rotenone can lead to the death,dopaminergic neurodegeneration and abnormal mito-UPR of transgenic nematodes with zcIs9; otIs181,while the VHL inhibitor can decrease the death rate and alleviate dopaminergic neurodegeneration of rotenone-induced C.elegans model of PD.The VHL inhibitor can also attenuate the behavioral abnormalities of head thrashes,body bends and foraging behavior of C.elegans model.These results suggest that rotenone may cause mitochondrial damage in the transgenic nematodes with zcIs9; otIs181, and then destroy mitochondrial homeostasis,thereby resulting in dopaminergic neurodegeneration and death of the nematodes. The VHL inhibitor VH298 may promote the survival of rotenone-induced C.elegans model of PD,and alleviate dopaminergic neurodegeneration,thereby improving the behavioral abnormalities of C.elegans model of PD.
  • [1]
    . JAMA,2020,323(6):548-560.
    [2]
    Martinez BA,Petersen DA,Gaeta AL,et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson''s disease[J]. J Neurosci,2017,37(46):11085-11100.
    [3]
    Runkel ED,Liu S,Baumeister R,et al. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response[J]. PLoS Genet,2013,9(3):e1003346.
    [4]
    Schmidt E,Seifert M,Baumeister R. Caenorhabditis elegans as a model system for Parkinson''s disease[J]. Neurodegener Dis,2007,4(2/3):199-217.
    [5]
    Shaye DD,Greenwald I. OrthoList:a compendium of C. elegans genes with human orthologs[J]. PLoS One,2011,6(5):e20085.
    [6]
    Kaletta T,Hengartner MO. Finding function in novel targets:C. elegans as a model organism[J]. Nat Rev Drug Discov,2006,5(5):387-398.
    [7]
    Culetto E,Sattelle DB. A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes[J]. Hum Mol Genet,2000,9(6):869-877.
    [8]
    Harrington AJ,Hamamichi S,Caldwell GA,et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson''s disease[J]. Dev Dyn,2010,239(5):1282-1295.
    [9]
    Li J,Le WD. Modeling neurodegenerative diseases in Caenorhabditis elegans[J]. Exp Neurol,2013,250:94-103.
    [10]
    González-Hunt CP,Leung MC,Bodhicharla RK,et al. Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans[J]. PLoS One,2014,9(12):e114459.
    [11]
    Lehtonen ?,Jaronen M,Vehvil?inen P,et al. Inhibition of excessive oxidative protein folding is protective in MPP(+) toxicity-induced Parkinson''s disease models[J]. Antioxid Redox Signal,2016,25(8):485-497.
    [12]
    Cooper JF,Dues DJ,Spielbauer KK,et al. Delaying aging is neuroprotective in Parkinson''s disease:a genetic analysis in C. elegans models[J]. NPJ Parkinsons Dis,2015,1:15022.
    [13]
    Chen S,Luo S,Zhang Z,et al. VHL-1 inactivation and mitochondrial antioxidants rescue C. elegans dopaminergic neurodegeneration[J]. Protein Cell,2019,10(8):610-614.
    [14]
    Stiernagle T. Maintenance of C. elegans[J]. WormBook,2006,11:1-11.
    [15]
    Brenner S. The genetics of Caenorhabditis elegans[J]. Genetics,1974,77(1):71-94.
    [16]
    Cao X,Wang X,Chen H,et al. Neurotoxicity of nonylphenol exposure on Caenorhabditis elegans induced by reactive oxidative species and disturbance synthesis of serotonin[J]. Environ Pollut,2019,244:947-957.
    [17]
    Tsai CW,Tsai RT,Liu SP,et al. Neuroprotective effects of betulin in pharmacological and transgenic Caenorhabditis elegans models of Parkinson''s disease[J]. Cell Transplant,2017,26(12):1903-1918.
  • Related Articles

    [1]YU Juping, LIU Wei, YE Meng, TANG Dongyang, GAO Xiangdong. Effect of homologous overexpression of nucleoside diphosphate kinase on the yield and molecular weight of hyaluronic acid[J]. Journal of China Pharmaceutical University, 2022, 53(2): 232-238. DOI: 10.11665/j.issn.1000-5048.20220214
    [2]JIANG Liya, LUO Ping, DENG Shaorong, YE Hao, YU Yan, HAN Wei. Antitumor effect of recombinant mouse interleukin-33 in mice[J]. Journal of China Pharmaceutical University, 2020, 51(5): 584-590. DOI: 10.11665/j.issn.1000-5048.20200510
    [3]LI Chengfei, CHEN Ling, WU Xuri. Regio-selective glycosylation of mogroside IIIE by glycosyltransferase[J]. Journal of China Pharmaceutical University, 2019, 50(2): 222-229. DOI: 10.11665/j.issn.1000-5048.20190214
    [4]JIN Yue, WU Xuri, CHEN Yijun. Applications of glycosyltransferases in the improvement of druggability of natural products[J]. Journal of China Pharmaceutical University, 2017, 48(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20170504
    [5]XIA Yang, HU Lingling, CHEN Jiao, LU Wuguang, YAN Huaijiang, HUO Jiege, CAO Peng. Cloning and expression of recombinant BmkNaTx12, a new voltage-gated sodium channel from scorpion Buthus martensii Karsch[J]. Journal of China Pharmaceutical University, 2017, 48(2): 220-226. DOI: 10.11665/j.issn.1000-5048.20170214
    [6]WANG Yuanxi, CHEN Junsheng, SHAO Lei, LI Ji′an, LIN Huimin, CHEN Daijie. Heterologous expression and in vitro activity of vancomycin glycosyltransferase GtfE[J]. Journal of China Pharmaceutical University, 2013, 44(3): 272-276. DOI: 10.11665/j.issn.1000-5048.20130317
    [7]ZHAO Na, SUN Hong-bin. Poly(ADP-ribose) polymerase inhibitors and synthetic lethality[J]. Journal of China Pharmaceutical University, 2012, 43(2): 107-112.
    [8]LIN Yu-shuang, HONG Wen-rong. Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes[J]. Journal of China Pharmaceutical University, 2012, 43(1): 92-96.
    [9]Construction of a high epidaunorubicin-producing strain by gene recombination[J]. Journal of China Pharmaceutical University, 2010, 41(3): 283-288.
    [10]PENG Chen, GE Hao, HE Shu-ying, GAO Xiang-dong. Molecular cloning,expression and identification of recombinant hyaluronan synthase from Pasteurella multocida[J]. Journal of China Pharmaceutical University, 2009, 40(6): 549-552.
  • Cited by

    Periodical cited type(1)

    1. 马小翔,马泽源,刘亚月,周龙建,和羿帆,张翼. 仿突变生物合成调控对土曲霉C23-3次生代谢产物的影响. 生物技术通报. 2024(08): 275-287 .

    Other cited types(0)

Catalog

    Article views (309) PDF downloads (721) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return